Loading...
Carcinoid tumours.
The use of long-acting and potent somatostatin analogues is a major advance in the management of carcinoid tumours. In addition to providing effective symptom relief in malignant carcinoid syndrome, octreotide can also be used for diagnostic purposes. Despite its expense, octreotide is the current a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Group
1997
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2431281/ https://ncbi.nlm.nih.gov/pubmed/9156122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|